Article
DRD4 48 bp multiallelic variants as age-population-specific biomarkers in attention-deficit/hyperactivity disorder.
Translational psychiatry - 19 Feb 2020
Bonvicini Cristian, Cortese Samuele, Maj Carlo, Baune Bernhard T, Faraone Stephen V, Scassellati Catia
Abstract excerpt
The identification of biomarkers to support the diagnosis and prediction of treatment response for attention-deficit/hyperactivity disorder (ADHD) is still a challenge. Our previous works highlighted the DRD4 (dopamine receptor D4) as the best potential genetic marker for childhood diagnosis and methylphenidate (MPH) response. Here, we aimed to provide additional evidence on biomarkers for ADHD diagnosis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
